|1.||Efroni, Sol: 2 articles (01/2012 - 01/2011)|
|2.||Ben-Hamo, Rotem: 2 articles (01/2012 - 01/2011)|
|3.||Ge, Juan: 1 article (05/2013)|
|4.||Zhou, Xinhua: 1 article (05/2013)|
|5.||Han, Xiqun: 1 article (05/2013)|
|6.||Zhao, Tong: 1 article (05/2013)|
|7.||Wu, Ziqin: 1 article (05/2013)|
|8.||Dai, Xinzhen: 1 article (05/2013)|
|9.||Chen, Shaohong: 1 article (05/2013)|
|10.||Meijer, C J L M: 1 article (01/2013)|
01/03/2013 - "These findings support a potential oncogenic function of hsa-miR-9 in cervical cancer. "
10/21/2010 - "Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma."
10/21/2010 - "In this study, we show that two genes encoding for hsa-miR-9 are significantly hypermethylated in ccRCC tumors compared with adjacent normal tissues (P-value <0.001 for both miR-9-1 and miR-9-3) resulting in decreased expression, and that the methylation of these genes was more significant in DNA obtained from the primary tumor for patients who developed a recurrence (P-value: 0.012 and 0.009 for miR-9-1 and miR-9-3, respectively) than in tumors from nonrecurrent patients. "
|2.||Glioblastoma (Glioblastoma Multiforme)
01/01/2012 - "Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression."
01/01/2011 - "Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression."
|3.||Melanoma (Melanoma, Malignant)
|4.||Renal Cell Carcinoma (Grawitz Tumor)
|5.||Burkitt Lymphoma (Burkitt's Lymphoma)
05/01/2013 - "To investigate the differential expression pattern of hsa-miR-9 between EBV-positive and -negative Burkitt lymphoma cell lines and its association with BCL-6. "
05/01/2013 - "[Expression pattern of hsa-miR-9 and its association with BCL6 in EBV-positive and EBV-negative Burkitt lymphoma cell lines]."
|1.||DNA (Deoxyribonucleic Acid)